Subsequent Events	12 Months Ended
Dec. 31, 2022
Subsequent Events [Abstract]
Subsequent Events	Note 24. Subsequent Events On March 2, 2023, the Company entered into a securities purchase agreement pursuant to which it sold in a private placement (i) 165,500 shares of common stock (“March 2023 PIPE Shares”), (ii) pre-funded common stock purchase warrants (“March 2023 Pre-Funded Warrants”) to purchase up to 500,834 shares of common stock, at an exercise price of $0.0001 per share, and (iii) preferred investment options (“March 2023 Options”) to purchase up to 1,332,668 shares of common stock, at an exercise price of $9.00 per share, for gross proceeds of $6.0 million (the “March 2023 PIPE”). The March 2023 PIPE closed on March 6, 2023. At the closing of the March 2023 PIPE, the Company also reduced the exercise price of outstanding warrants to purchase a total of 178,132 shares of common stock that were previously issued to the investors in the March 2023 PIPE. The March 2023 Pre-Funded Warrants became exercisable upon issuance and are exercisable until exercised in full. The March 2023 Options became exercisable upon issuance with 666,334 options expiring 18 months after the date of issuance and the remaining 666,334 options expiring 5 years after the date of issuance. The Company agreed to register the resale of the March 2023 PIPE Shares and the shares issuable upon exercise of the March 2023 Pre-Funded Warrants and March 2023 Options. In connection with the March 2023 PIPE, the Company granted to a placement agent preferred investment options ("March 2023 Placement Agent Options") to purchase a total of 33,317 shares of common stock that have an exercise price per share equal to $11.25 and a term of five years.

Subsequent Events

12 Months Ended

Dec. 31, 2022

Note 24. Subsequent Events

On March 2, 2023, the Company entered into a securities purchase agreement pursuant to which it sold in a private placement (i) 165,500 shares of common stock (“March 2023 PIPE Shares”), (ii) pre-funded common stock purchase warrants (“March 2023 Pre-Funded Warrants”) to purchase up to 500,834 shares of common stock, at an exercise price of $0.0001 per share, and (iii) preferred investment options (“March 2023 Options”) to purchase up to 1,332,668 shares of common stock, at an exercise price of $9.00 per share, for gross proceeds of $6.0 million (the “March 2023 PIPE”). The March 2023 PIPE closed on March 6, 2023. At the closing of the March 2023 PIPE, the Company also reduced the exercise price of outstanding warrants to purchase a total of 178,132 shares of common stock that were previously issued to the investors in the March 2023 PIPE. The March 2023 Pre-Funded Warrants became exercisable upon issuance and are exercisable until exercised in full. The March 2023 Options became exercisable upon issuance with 666,334 options expiring 18 months after the date of issuance and the remaining 666,334 options expiring 5 years after the date of issuance. The Company agreed to register the resale of the March 2023 PIPE Shares and the shares issuable upon exercise of the March 2023 Pre-Funded Warrants and March 2023 Options. In connection with the March 2023 PIPE, the Company granted to a placement agent preferred investment options ("March 2023 Placement Agent Options") to purchase a total of 33,317 shares of common stock that have an exercise price per share equal to $11.25 and a term of five years.